[25-011814] DNA sequencing and genomics core requires the illumina reagents/kits in order to to prepare experiments for nhlbi's staffs, PIS, and fellows
Ended Awarded Last action
- Contract number
- 75N92025F00012
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $62,443
Award facts
- Contract value 100% obligated
- $62,443.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order to Illumina, Inc. valued at $62,443.41 for DNA sequencing and genomics reagents and kits. This firm fixed-price contract, awarded June 27, 2025 with completion targeted for August 27, 2025, will support the NHLBI's DNA Sequencing and Genomics Core facility in preparing experiments for the institute's staff, principal investigators, and fellows. Illumina, a leading biotechnology company headquartered in San Diego, California, specializes in genetic sequencing and genomic analysis technologies, providing advanced instrumentation, reagents, consumables, and bioinformatics software to federal agencies. The contract carries no set-aside designation, reflecting Illumina's specialized technological capabilities in the genomic sequencing market.
This delivery order represents a continuation of the NHLBI's ongoing relationship with Illumina for genomic research support. As a component of the National Institutes of Health, the NHLBI leverages advanced sequencing technologies to support cardiopulmonary and hematological research initiatives. Illumina's provision of specialized reagent kits and consumables enables the institute's researchers to conduct comprehensive genetic analysis and exploration critical to understanding disease mechanisms and developing therapeutic interventions. The San Diego location of performance aligns with Illumina's primary operations and ensures direct access to manufacturing and technical expertise for this critical research support contract.
Quick answers
Who was awarded contract 75N92025F00012?
75N92025F00012 was awarded to Illumina, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on June 27, 2025.
How much is contract 75N92025F00012 worth?
The government has obligated $62,443 on 75N92025F00012.
Is contract 75N92025F00012 an order under another contract?
Yes. 75N92025F00012 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92025F00012 competed?
The extent of competition for 75N92025F00012 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award